Fox Run Management L.L.C. lifted its holdings in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 121.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,166 shares of the technology company's stock after buying an additional 22,057 shares during the period. Fox Run Management L.L.C.'s holdings in Koninklijke Philips were worth $1,020,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Choreo LLC grew its holdings in shares of Koninklijke Philips by 4.6% in the first quarter. Choreo LLC now owns 14,530 shares of the technology company's stock valued at $369,000 after purchasing an additional 633 shares during the period. Allworth Financial LP boosted its holdings in Koninklijke Philips by 16.2% in the 1st quarter. Allworth Financial LP now owns 4,638 shares of the technology company's stock valued at $115,000 after purchasing an additional 645 shares during the last quarter. GeoWealth Management LLC grew its stake in shares of Koninklijke Philips by 4.5% in the 4th quarter. GeoWealth Management LLC now owns 19,255 shares of the technology company's stock valued at $488,000 after buying an additional 825 shares during the period. Assetmark Inc. grew its stake in shares of Koninklijke Philips by 1.7% in the 1st quarter. Assetmark Inc. now owns 59,806 shares of the technology company's stock valued at $1,519,000 after buying an additional 982 shares during the period. Finally, US Bancorp DE increased its holdings in shares of Koninklijke Philips by 0.9% during the 1st quarter. US Bancorp DE now owns 109,831 shares of the technology company's stock worth $2,790,000 after buying an additional 1,014 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy".
Read Our Latest Stock Analysis on PHG
Koninklijke Philips Stock Up 0.7%
Shares of NYSE PHG traded up $0.2050 during mid-day trading on Wednesday, hitting $27.7750. The company had a trading volume of 923,569 shares, compared to its average volume of 1,244,223. The business's 50-day simple moving average is $25.03 and its 200 day simple moving average is $25.01. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.26 and a quick ratio of 0.81. The company has a market capitalization of $26.75 billion, a PE ratio of 146.18, a price-to-earnings-growth ratio of 0.75 and a beta of 0.75. Koninklijke Philips N.V. has a 1-year low of $21.48 and a 1-year high of $32.91.
Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.12. The business had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $4.35 billion. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%. On average, analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current year.
About Koninklijke Philips
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.